Sep. 3 at 12:33 PM
$WINT
Insiders what are they doing after 90% drop??
I pulled the SEC Form-4s and recent company filings for WINT (Windtree Therapeutics) and focused on insider purchases/sales in the last ~12 months (since Sept 3, 2024). Short answer first: there has been essentially no meaningful insider buying in the past 12 months, and the small filings that do exist are either token purchases or participation in private financings (preferred/warrants) rather than open-market buys that would signal confidence. Meanwhile the company’s recent SEC 8-Ks show multiple private financings and convertible/warrant issuance — the kind of activity that creates dilution and explains heavy downward pressure on the equity.